Crescent Biopharma Inc (CBIO)

Oct 10, 2025

Will Crescent Biopharma Inc. (GKO0) stock beat value stocksJuly 2025 Technicals & Safe Capital Growth Plans - newser.com

Oct 10, 2025

Oct 09, 2025

GlycoMimetics adjusts merger terms with Crescent Biopharma - MSN

Oct 09, 2025

Oct 05, 2025

Will Crescent Biopharma Inc. (GKO0) stock benefit from Fed rate cutsJuly 2025 Update & Safe Entry Zone Identification - newser.com

Oct 05, 2025

Oct 04, 2025

Short Interest in Crescent Biopharma, Inc. (NASDAQ:CBIO) Grows By 103.8% - MarketBeat

Oct 04, 2025

Oct 03, 2025

Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives $25.60 Consensus Target Price from Analysts - Defense World

Oct 03, 2025

Oct 03, 2025

Will Crescent Biopharma Inc. (GKO0) stock top growth indexesIPO Watch & AI Driven Stock Reports - newser.com

Oct 03, 2025

Oct 03, 2025

Will Crescent Biopharma Inc. (GKO0) stock hit Wall Street targetsJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com

Oct 03, 2025

Sep 30, 2025

Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Sep 30, 2025

Sep 29, 2025

GlycoMimetics Shares Are Soaring Tuesday: Here's Why - MSN

Sep 29, 2025

Sep 28, 2025

What analysts say about Crescent Biopharma Inc GKO0 stockVolatility Adjusted Trading & Superior Wealth Building - earlytimes.in

Sep 28, 2025

Sep 23, 2025

Crescent Biopharma (NASDAQ:CBIO) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Sep 23, 2025

Sep 18, 2025

Crescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200-Day Moving AverageShould You Sell? - MarketBeat

Sep 18, 2025

Sep 17, 2025

With 36% stake, Crescent Biopharma, Inc. (NASDAQ:CBIO) seems to have captured institutional investors' interest - Yahoo Finance

Sep 17, 2025

Sep 13, 2025

Jefferies Initiates Crescent Biopharma(CBIO.US) With Buy Rating, Announces Target Price $26 - 富途牛牛

Sep 13, 2025

Sep 13, 2025

LifeSci Capital Maintains Crescent Biopharma(CBIO.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛

Sep 13, 2025

Sep 13, 2025

H.C. Wainwright Maintains Crescent Biopharma(CBIO.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛

Sep 13, 2025

Sep 09, 2025

Crescent Biopharma (NASDAQ:CBIO) Stock Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 09, 2025

Sep 08, 2025

Analysts Set Crescent Biopharma, Inc. (NASDAQ:CBIO) Price Target at $25.60 - Defense World

Sep 08, 2025

Sep 04, 2025

Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World

Sep 04, 2025

Aug 30, 2025

Crescent Biopharma to Present at September Investor Conferences - AInvest

Aug 30, 2025

Aug 30, 2025

Crescent Biopharma (NASDAQ:CBIO) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat

Aug 30, 2025

Aug 28, 2025

Crescent Biopharma (NASDAQ:CBIO) Given Buy Rating at HC Wainwright - Defense World

Aug 28, 2025

Aug 28, 2025

Cancer Drug Developer Crescent Biopharma to Present at Major September Healthcare Conferences - Stock Titan

Aug 28, 2025

Aug 27, 2025

Stifel reiterates Buy rating on Crescent Biopharma stock at $28 target - Investing.com

Aug 27, 2025

Aug 26, 2025

Devon Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - AInvest

Aug 26, 2025

Aug 25, 2025

This Devon Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Aug 25, 2025

Aug 25, 2025

Jefferies Initiates Coverage of Crescent Biopharma with Buy Rating and $26 Price Target - AInvest

Aug 25, 2025

Aug 25, 2025

Jefferies initiates coverage on Crescent Biopharma stock with Buy rating By Investing.com - Investing.com Nigeria

Aug 25, 2025

Aug 25, 2025

Jefferies initiates coverage on Crescent Biopharma stock with Buy rating - Investing.com

Aug 25, 2025